Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Dyskinesias × Rivaroxaban × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1 CNS 1

Conditions

Venous Thromboembolism 3 Venous Thrombosis 2 Pulmonary Embolism 2 Neoplasms 2 Thrombosis 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioma 1 Dyskinesias 1

Interventions

Rivaroxaban 1 Long-Term Synaptic Depression 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown

CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡